ArticleClinical endocrinology2026
Subacute Thyroiditis in Denmark: A Nationwide Study of 1763 Cases.
Article in Clinical endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- How to manage subacute thyroiditis.Drugs in context · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
objectiveSubacute thyroiditis (SAT) is a differential diagnosis in the clinical care of hypo- and hyperthyroid patients, but large-scale population data on the incidence, patient characteristics, and outcome are limited. Thus, the aim was to determine the incidence of SAT in the Danish population and to characterise patient demographics and the risk of permanent hypothyroidism.
designRetrospective cohort study based on Danish nationwide health registers. PATIENTS: Individuals diagnosed with SAT at Danish hospitals from 1995 to 2016, covering the years before and after the implementation of mandatory iodine fortification in Denmark as of July 2000. MEASUREMENTS: Annual incidence rates of SAT were calculated overall and by geographical region (East and West Denmark). The development of permanent hypothyroidism following SAT was evaluated based on redeemed prescriptions of levothyroxine (L-T4) within a 4-year follow-up period.
resultsA total of 1763 individuals were identified with a diagnosis of SAT among 1,747,168 individuals at risk. The overall nationwide incidence increased from 3.3/100,000 individuals (95% confidence interval (CI): 2.5-4.4) in 1995 to 6.2/100,000 individuals (95% CI: 5.1-7.6) in 2016, with no regional difference (p = 0.18). Follow-up showed that 459 of 1763 patients with SAT (26.0%) started treatment with L-T4, and in 224 of these patients (48.7%), the duration of L-T4 treatment exceeded 36 months.
conclusionsIn a Danish nationwide cohort, the incidence of SAT increased during a 22-year period without geographical difference. Notably, the frequency of long-term L-T4 treatment was high, emphasising a focus on the post-diagnosis management of patients with SAT.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.